Ana Portelinha

Also affiliated with Kettering University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors”.

ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100350

N/A

0DataRank · unranked

24 citations

Scott K. Thompson, Roger A. Smith, Mariana Da Silva Ferreira, Zahra Asgari, Andrea Knežević +7 more

Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma

Nature Communications(2023)10.1038/s41467-023-37216-2

N/A

0DataRank · unranked

14 citations

Mariana Da Silva Ferreira, Tatiana Erazo, Man Jiang, Zahra Asgari, Elisa de Stanchina +3 more

SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma

The Journal of Experimental Medicine(2024)10.1084/jem.20231143

N/A

0DataRank · unranked

11 citations

Shenqiu Wang, Sara Parsa, Man Jiang, Alexander N. Gorelick, Sagarajit Mohanty +14 more